U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 22-28, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 22-28, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 08/25/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 08/26/2021
Location: Virtul
Subject: World Orphan Drug Congress USA
FDA Participant/Group: PETER MARKS; JANET MAYNARD; SUSAN CHITTOORAN;
Non FDA Participant/Group: Industry, media, government, and other registered guests

Event Date: 08/27/2021
Location: Virtual
Subject: Selection Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Patient-Centered Outcomes Research Institute

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/24/2021
Location: Virtual
Subject: New Era of Smarter Food Safety Update, 4th Almarai Food Safety Conference 2021
FDA Participant/Group: N/A
Non FDA Participant/Group: Food industry, academia, and regulatory agencies

Event Date: 08/26/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; CAITLIN BOON;
Non FDA Participant/Group: Betsy Booren, Geoff Freeman, Roberta Wagner (Consumer Brands Association);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 08/22/2021
Location: Virtual
Subject: Expediting the Development of Vaccines for Public Health Emergencies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Division of Biochemical Technology / American Chemical Society 262nd National Meeting

Event Date: 08/28/2021
Location: Virtual
Subject: Update on COVID-19 in the Pediatric Population: Update on Vaccine Trials for Children under 12
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Centers for Disease Control and Prevention (CDC)/ Infectious Diseases Society of America (IDSA) COVID-19 Clinician Call

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top